197 related articles for article (PubMed ID: 35469998)
41. Helicobacter pylori infection and gastric carcinogenesis in rodent models.
Tsukamoto T; Toyoda T; Mizoshita T; Tatematsu M
Semin Immunopathol; 2013 Mar; 35(2):177-90. PubMed ID: 23111700
[TBL] [Abstract][Full Text] [Related]
42. Curcumin Encapsulated into Biocompatible Co-Polymer PLGA Nanoparticle Enhanced Anti-Gastric Cancer and Anti-Helicobacter Pylori Effect.
Alam J; Dilnawaz F; Sahoo SK; Singh DV; Mukhopadhyay AK; Hussain T; Pati S
Asian Pac J Cancer Prev; 2022 Jan; 23(1):61-70. PubMed ID: 35092372
[TBL] [Abstract][Full Text] [Related]
43. [Helicobacter pylori-related diseases].
Gisbert JP
Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():39-50. PubMed ID: 24160951
[TBL] [Abstract][Full Text] [Related]
44. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
Hawkey CJ
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S17-20. PubMed ID: 10929894
[TBL] [Abstract][Full Text] [Related]
45. Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model.
Zhang S; Lee DS; Morrissey R; Aponte-Pieras JR; Rogers AB; Moss SF
Cancer Lett; 2014 Dec; 355(1):106-12. PubMed ID: 25218349
[TBL] [Abstract][Full Text] [Related]
46. Focusing on
Gong H; Xu HM; Zhang DK
Front Cell Infect Microbiol; 2023; 13():1121947. PubMed ID: 36968116
[TBL] [Abstract][Full Text] [Related]
47. Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model.
Santos AM; Lopes T; Oleastro M; Gato IV; Floch P; Benejat L; Chaves P; Pereira T; Seixas E; Machado J; Guerreiro AS
Nutrients; 2015 Jan; 7(1):306-20. PubMed ID: 25569625
[TBL] [Abstract][Full Text] [Related]
48. Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised?
Lee SY
J Gastroenterol Hepatol; 2012 Feb; 27(2):200-11. PubMed ID: 22098099
[TBL] [Abstract][Full Text] [Related]
49. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication.
Pan KF; Zhang L; Gerhard M; Ma JL; Liu WD; Ulm K; Wang JX; Zhang L; Zhang Y; Bajbouj M; Zhang LF; Li M; Vieth M; Liu RY; Quante M; Wang LH; Suchanek S; Zhou T; Guan WX; Schmid R; Classen M; You WC
Gut; 2016 Jan; 65(1):9-18. PubMed ID: 25986943
[TBL] [Abstract][Full Text] [Related]
50. Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Gong EJ; Ahn JY; Jung HY; Park H; Ko YB; Na HK; Jung KW; Kim do H; Lee JH; Choi KD; Song HJ; Lee GH; Kim JH
Gut Liver; 2016 Sep; 10(5):706-13. PubMed ID: 27114423
[TBL] [Abstract][Full Text] [Related]
51. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Ford AC; Delaney BC; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2006 Apr; (2):CD003840. PubMed ID: 16625592
[TBL] [Abstract][Full Text] [Related]
52. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation.
Thamphiwatana S; Gao W; Obonyo M; Zhang L
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17600-5. PubMed ID: 25422427
[TBL] [Abstract][Full Text] [Related]
53. Helicobacter Pylori and Gastric Cancer: Clinical Aspects.
Song ZQ; Zhou LY
Chin Med J (Engl); 2015 Nov; 128(22):3101-5. PubMed ID: 26608993
[TBL] [Abstract][Full Text] [Related]
54. Management of Helicobacter pylori infection after gastric surgery.
Lin YS; Chen MJ; Shih SC; Bair MJ; Fang CJ; Wang HY
World J Gastroenterol; 2014 May; 20(18):5274-82. PubMed ID: 24833857
[TBL] [Abstract][Full Text] [Related]
55. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
Gonçalves IC; Henriques PC; Seabra CL; Martins MC
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):981-92. PubMed ID: 24981812
[TBL] [Abstract][Full Text] [Related]
56. Helicobacter pylori as a class I carcinogen: physiopathology and management strategies.
Vogiatzi P; Cassone M; Luzzi I; Lucchetti C; Otvos L; Giordano A
J Cell Biochem; 2007 Oct; 102(2):264-73. PubMed ID: 17486575
[TBL] [Abstract][Full Text] [Related]
57. [The association between Helicobacter pylori and gastric cancer: the role of infection's eradication. Recent advances].
Eusebi LH; Ceroni L; Laterza L; Kurelac I; Fuccio L
Recenti Prog Med; 2010 Feb; 101(2):66-9. PubMed ID: 20433004
[TBL] [Abstract][Full Text] [Related]
58. [The effect of Helicobacter pylori eradication on chronic gastritis].
Kodama M; Murakami K; Okimoto T; Fujioka T
Nihon Rinsho; 2013 Aug; 71(8):1442-8. PubMed ID: 23967677
[TBL] [Abstract][Full Text] [Related]
59. Population screening and treatment of Helicobacter pylori infection.
O'Connor A; O'Morain CA; Ford AC
Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):230-240. PubMed ID: 28053340
[TBL] [Abstract][Full Text] [Related]
60. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
